Dr. Anuoluwapo A. Shobayo, MD

Dr. Shobayo practices at Brown Medicine in Riverside, Rhode Island.

Dr. Shobayo's NPI, 1659895795, was assigned on July 31, 2017. Dr. Shobayo holds Rhode Island license MD18340.

Dr. Shobayo's primary practice is Brown Medicine, at 375 Wampanoag Trl, Riverside, RI 02915 in Providence County. The practice phone is (401) 444-7793.

Dr. Shobayo's primary practice is Brown Medicine in Riverside, Rhode Island. Dr. Shobayo is also affiliated with The Miriam Hospital. The medical group on file is Brown Medicine. Dmand AI also links Dr. Shobayo to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shobayo practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Shobayo's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Shobayo is licensed in Rhode Island.

CMS data shows 48 Medicare services from Dr. Shobayo across 2 procedure codes in 2024, for 60 Medicare patients. Medicare paid $5,475 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Shobayo in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shobayo's median patient age at 63, with 42% women.

In 2024, Dr. Shobayo wrote 858 Medicare Part D claims for 97 patients. 57% of them were for generic drugs. CMS names the drug for 648 of them, across 28 drugs with 11 or more claims each, at $838,406 in total drug cost. In 2023, CMS named 259 claims across 10 drugs.

Dr. Shobayo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Shobayo, published from 2019 to 2022. 2019 was the busiest year, with 2. Dr. Shobayo's most frequent co-authors are Edward Kurt Chapnick, MD, Yousef Elfanagely, MD and Krishna Sai Kommineni, MBBS.

CMS Open Payments shows 4 general payments to Dr. Shobayo from 1 drug or device company from 2020 to 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $82.